Table 1. Demographics, Number of Patients and Presentation of Patients With Prostate Cancer in Sub-Saharan Africa.

Study	Study design	Number of patients	Mean age in years	Age range in years	Presentation
Niang et al (Senegal) [8]	Retrospective study	164	65	43 - 96	LUTS/suspicious DRE/elevated PSA
Amegbor et al (Togo) [12]	Retrospective study	202	70	45 - 95
Ndoye et al (Senegal) [13]	Retrospective study	102	71 ± 9	51 - 96	Back pain/LUTS/suspicious DRE/neurological signs
Tengue et al (Togo) [14]	Prospective study	232	68.5 ± 9.6		Back pain/LUTS
Anunobi et al (Nigeria) [15]	Retrospective study	222	66	60 - 69
Kyei et al (Ghana) [10]	Prospective study	20	62.7	51 - 72	LUTS
Kabore et al (Burkina) [16]	Prospective study	168	68.59 ± 9.41	30 - 95	LUTS/suspicious DRE/elevated PSA
Wasike et al (Kenya) [17]	Prospective study	65	67	50 - 100	Suspicious DRE/elevated PSA
Kabore et al (Burkina) [18]	Prospective study	166	71.5	52 - 86	LUTS/suspicious DRE/elevated PSA
Gueye et al (Senegal) [19]	Retrospective study	121	69	52 - 88	LUTS
Obiorah et al (Nigeria) [20]	Retrospective study	198	70	42 - 90
Babacar et al (Senegal) [21]	Retrospective study	35	63 ± 5.9	41 - 74
Badmus et al (Nigeria) [22]	Retrospective study	189	68	40 - 100	LUTS/suspicious DRE
Mawakyoma et al (Tanzania) [23]	Prospective study	113	68	48 - 100

DRE: digital rectal exam; LUTS: lower urinary tract symptoms; PSA: prostate specific antigen.